Great American SmokeoutNovember 16, 2017
The American Cancer Society's Great American Smokeout is an annual event that encourages smokers to make a plan to quit smoking (1) . The 42nd annual Great American Smokeout will be held on November 16, 2017.
In the more than 50 years since the Surgeon General's first report on smoking and health, cigarette smoking among U.S. adults has been reduced by approximately half. Nonetheless, since 1964, the year of that first report, an estimated 20 million persons have died because of smoking. Smoking remains the leading preventable cause of disease, disability, and death in the United States (2) .
About two out of three adult smokers want to quit smoking cigarettes, and approximately half of smokers made a quit attempt in the preceding year (2) . However, in 2016, more than one in seven U.S. adults were current cigarette smokers (3) . Getting effective help through counseling and use of medications can increase the chances of quitting by as much as threefold (4) .
Information and support for quitting smoking is available by telephone at 800-QUIT-NOW (800-784-8669). CDC's Tips From Former Smokers campaign offers additional quit resources at https://www.cdc.gov/tips.
Tobacco use remains the leading cause of preventable disease and death in the United States (1) . Despite declining cigarette smoking prevalence among U.S. adults, shifts in the tobacco product landscape have occurred in recent years (2, 3) . Previous estimates of tobacco product use among U.S. adults were obtained from the National Adult Tobacco Survey, which ended after the 2013-2014 cycle. This year, CDC and the Food and Drug Administration (FDA) assessed the most recent national estimates of tobacco product use among adults aged ≥18 years using, for the first time, data from the 2015 National Health Interview Survey (NHIS), an annual, nationally representative, in-person survey of the noninstitutionalized U.S. civilian population. The 2015 NHIS adult core questionnaire included 33,672 adults aged ≥18 years, reflecting a 55.2% response rate. Data were weighted to adjust for differences in selection probability and nonresponse, and to provide nationally representative estimates. In 2015, 20.1 % of U.S. adults currently (every day or some days) used any tobacco product, 17.6% used any combustible tobacco product, and 3.9% used ≥2 tobacco products. By product, 15.1% of adults used cigarettes; 3.5% used electronic cigarettes (e-cigarettes); 3.4% used cigars, cigarillos, or filtered little cigars; 2.3% used smokeless tobacco; and 1.2% used regular pipes, water pipes, or hookahs.* Current use of any tobacco product was higher among males; persons aged <65 years; non-Hispanic American Indian/Alaska natives (AI/AN), whites, blacks, and persons of multiple races; persons living in the Midwest; persons with a General Educational Development (GED) certificate; persons with annual household income of <$35,000; persons who were single, never married, or not living with a partner or divorced, separated, or widowed; persons who were insured through Medicaid or uninsured; persons with a disability; and persons who identified as lesbian, gay, or bisexual (LGB). Current use of any tobacco product was 47.2% among adults with serious psychological distress compared with 19.2% among those without serious psychological distress. Proven population-level interventions that focus on the diversity of tobacco product use * Because of phrasing of the question in the 2015 NHIS, it was not possible to distinguish between regular pipe use and water pipe or hookah use in this analysis.
are important to reducing tobacco-related disease and death in the United States (1). Consistent with previous reports (2,3), current cigarette smokers were defined as persons who reported they had smoked ≥100 cigarettes during their lifetime, and smoked either "every day" or "some days" at the time of survey. Current users of all other assessed tobacco products were defined as persons who reported use "every day" or "some days" at the time of survey. Prevalence estimates for current use of any current tobacco product, any combustible tobacco product (cigarettes, cigars, cigarillos, filtered little cigars, pipes, water pipes, or hookahs), and use of two or more tobacco products were calculated. Estimates were assessed overall and by sex, age, race/ethnicity, U.S. Census region, † § Sexual orientation was determined based on the question, "Which of the following best represents how you think of yourself?" with response options of "gay" ("lesbian or gay" for female respondents), "heterosexual," that is, "not gay" ("not lesbian or gay" for female respondents), "bisexual," "something else," and "I don't know the answer." Responses were considered to be "LGB" if persons responded "gay," "lesbian or gay," or "bisexual." insurance coverage, ¶ disability,** and presence of serious psychological distress. † † Significant differences between groups were assessed using chi-squared statistics; differences presented were all statistically significant (p<0.05).
Among U.S. adults in 2015, 20.1% (an estimated 48.7 million) currently used any tobacco product, 17.6% (42.6 million; 87.4% of current tobacco product users) currently used any combustible tobacco product, and 3.9% (9.5 million; 19.5%) currently used ≥2 tobacco products. By product, 15.1% (36.5 million; 74.9% of current users) of adults currently used cigarettes; 3.5% (7.9 million; 16.1%) used e-cigarettes; 3.4% (7.8 million; 16.0%) used cigars, cigarillos, or filtered little cigars; 2.3% (5.1 million; 10.5%) used smokeless tobacco; and 1.2% (2.7 million; 5.5%) used pipes, water pipes, or hookahs.
Differences in tobacco product use were observed across population groups (Table) . The prevalence of any current tobacco use was significantly higher among males (25.2%) than among females (15.4%) and among adults aged 25-44 years (23.3%) than among those aged ≥65 years (11.1%). Notably, the age distribution of current tobacco users varied by product type, and for pipes, water pipes, hookahs and e-cigarettes, use was highest among younger adults ( Figure) . By race/ethnicity, current use was higher among non-Hispanic AI/AN (26.6%), ¶ Private coverage: includes adults who had any comprehensive private insurance plan (including health maintenance organizations and preferred provider organizations 
Discussion
In 2015, approximately one in five U.S. adults (48.7 million) currently used any tobacco product, with most using combustible tobacco products. Any tobacco product use was significantly higher among males; adults aged <65 years; non-Hispanic AI/ AN, whites, blacks, and persons of multiple races; persons living in the Midwest; persons with a GED; persons with annual household income <$35,000; persons who were single/never married/ not living with a partner or divorced/separated/widowed; persons who were uninsured or insured through Medicaid; persons with a disability; and persons who identified as LGB. Adults with serious psychological distress had the highest prevalence of any tobacco product use of any subpopulation.
The burden of death and disease from tobacco use is overwhelmingly caused by cigarettes and other combusted tobacco products (1). Cigarette smoking has been declining among U.S. adults for several decades (1); in more recent years, prevalence declined from 20.9% in 2005 to 15.1% in 2015 (3). The findings from this report show that in 2015, cigarettes remained the most commonly used tobacco product among adults, and combustible tobacco products were currently used by 17.6% of adults, or 87.4% of current any tobacco users. Despite the popularity of emerging products such as pipes, water pipes, hookahs, and e-cigarettes among youths, these findings highlight the importance of also continuing to use targeted evidence-based, population-level strategies to combat combustible product use. These strategies include tobacco price increases, high-impact antitobacco mass media campaigns, comprehensive smoke-free laws, and enhanced access to help quitting tobacco to reduce smoking-related death and disease in the United States (1).
Observed disparities in tobacco product use across population groups likely have multiple contributing factors. For example, disparities in tobacco use by race/ethnicity might be partly explained by socio-cultural influences, norms surrounding the acceptability of tobacco use, and targeted marketing (1, 4) . Differences by education might be partly attributable to variations in understanding of the range of health hazards caused by tobacco product use (1, 4) . Differences by health insurance coverage and income might be attributable in part to variations in tobacco cessation coverage across insurance types and access to evidence-based cessation treatments, respectively (1, 5) . Furthermore, the higher prevalence of current tobacco product use among persons who identified as LGB might be due, in part, to social stressors including stigma and discrimination, in addition to targeted marketing efforts by the tobacco industry (1, 6) . Similarly, the higher rates of pipe, water pipe, hookah, and e-cigarette use among younger adults could be due to the manner in which these products are marketed and used socially (1, 7) . The tobacco industry has targeted marketing US Department of Health and Human Services/Centers for Disease Control and Prevention * For cigarettes, users were defined as persons who reported use either "every day" or "some days" and had smoked ≥100 cigarettes during their lifetime. 
FIGURE.
Percentage of use of tobacco product types* among adults aged ≥18 years who reported using tobacco products "every day" or "some days," by age group -National Health Interview Survey, United States, 2015
toward minority communities, persons of lower socioeconomic status, and younger persons (4, 6) . Lastly, the high prevalence of tobacco use among persons with serious psychological distress possibly reflects nicotine's stimulant or relaxation effects, nicotine's effects on drug metabolism, misperceptions about quitting smoking and abstinence success, and allowing smoking in mental health facilities (4, 8) .
The findings in this report are subject to at least three limitations. First, tobacco use estimates were self-reported and not validated by biochemical tests. However, previous studies have shown that self-reported tobacco product use is highly correlated with serum cotinine levels (9, 10) . Second, the NHIS response rate (55.2%) could introduce nonresponse bias if respondents and nonrespondents systematically differ in ways not accounted for in the development of the weights. Finally, NHIS does not include institutionalized populations and persons in the military, so the results are not generalizable to those groups.
Sustained, comprehensive state tobacco control programs can accelerate progress toward reducing tobacco-related diseases and deaths. § § Full implementation of comprehensive tobacco control programs, in conjunction with FDA regulation of tobacco products, across the spectrum of tobacco products, are vital (1) . Targeted interventions are also warranted to reach subpopulations with the greatest burden of use, which might vary by tobacco product type.
Summary
What is already known about this topic?
Tobacco use continues to be the leading cause of preventable disease and death in the United States. Despite declining cigarette smoking prevalence among U.S. adults, notable shifts in the tobacco product landscape have occurred in recent years.
What is added by this report?
In 2015, 20.1% of U.S. adults currently (every day or some days) used any tobacco product, 17.6% used any combustible tobacco product, and 3.9% used ≥2 tobacco products. Current use of any tobacco product was higher among males; persons aged <65 years; non-Hispanic American Indian/Alaska natives, whites, blacks, and persons of multiple races; persons living in the Midwest; persons with a General Educational Development certificate; persons with annual household income <$35,000; persons who were single/never married/not living with a partner or divorced/separated/widowed; persons who were insured through Medicaid or uninsured; persons with a disability; and persons who identified as lesbian, gay, or bisexual. Current use of any tobacco product was 47.2% among adults with serious psychological distress compared with 19.2% among those without serious psychological distress.
What are the implications for public health practice?
Full implementation of comprehensive tobacco control programs, in conjunction with FDA regulation of tobacco products, are vital across the spectrum of tobacco products. Targeted interventions are also warranted to reach subpopulations with the greatest burden of use, which might vary by tobacco product type.
